{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-23-003188","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.541497+00:00","generated_at":"2026-06-10T13:29:26.704521+00:00","sec_items":["5.02","8.01","5.07"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ReWalk Robotics shareholders reject director re-election; board shrinks to six; CEO gets RSUs and raise","bullets":["Shareholders failed to re-elect Yohanan Engelhardt as Class III director; he is no longer on board.","Three previously announced directors (Aryeh Dan, Yasushi Ichiki, Wayne Weisman) departed; board now six members.","Shareholders approved restated Compensation Policy, 200,000 RSU grant to CEO Larry Jasinski, and 5.5% salary increase to $442,312.","Advisory say-on-pay proposal failed with 26% support; Compensation Committee to consider results.","Shareholders authorized reverse share split range of 1-for-2 to 1-for-12 and increase in authorized shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-23-003188","json":"https://secwatch.observer/filing/0001178913-23-003188.json","markdown":"https://secwatch.observer/filing/0001178913-23-003188.md","text":"https://secwatch.observer/filing/0001178913-23-003188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/zk2330302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T13:29:26.704521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2648b299879c1f227c7dddc4ef4d0c3324ea1358","claim":"Lifeward Ltd. shareholders rejected To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement, pursuant to Item 402 of Regulation S-K of the SEC, including the compensation tables and accompanying narrative disclosures.","evidence_excerpt":"Proposal No. 8: To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement, pursuant to Item 402 of Regulation S-K of the SEC, including the compensation tables and accompanying narrative disclosures. For Against Abstain Broker Non-Votes 4,108,344 11,613,202 936,181 13,704,575","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"failed"}],"fact_type":"shareholder_vote"},{"claim_id":"369402055ff8663ecc5e4e952a57e1a922eda8e1","claim":"Lifeward Ltd. shareholders approved To approve (i) a one-time grant of 200,000 RSUs to Larry Jasinski, the Company’s CEO, and (ii) an increase in Mr. Jasinski’s annual salary by five and one-half percent (5.5%), effective January 1, 2023 at the 2023-01-01 meeting.","evidence_excerpt":"Proposal No. 2.: To approve (i) a one-time grant of 200,000 RSUs to Larry Jasinski, the Company’s CEO, and (ii) an increase in Mr. Jasinski’s annual salary by five and one-half percent (5.5%), effective January 1, 2023. For Against Abstain Broker Non-Votes 4,346,554 2,421,327 9,889,846 13,704,575","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-01-01"}],"fact_type":"shareholder_vote"},{"claim_id":"6701aca0ec7846154b2a7a038180967ef3602eaa","claim":"Lifeward Ltd. shareholders approved To approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent registered public accounting firm for the year ending December 31, 2023 and until the next annual meeting of shareholders, and to authorize the Board, upon recommendation of t at the 2023-12-31 meeting.","evidence_excerpt":"Proposal No. 7: To approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent registered public accounting firm for the year ending December 31, 2023 and until the next annual meeting of shareholders, and to authorize the Board, upon recommendation of the audit committee, to fix the remuneration of said independent registered public accounting firm . For Against Abstain 28,619,227 1,563,077 179,997","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-31"}],"fact_type":"shareholder_vote"},{"claim_id":"6be7b05eecacb82cef24c896e873b6223ec5b49a","claim":"Lifeward Ltd. shareholders rejected To reelect Yohanan Engelhardt as a Class III director.","evidence_excerpt":"Nominee For Against Abstain Broker Non-Votes Yohanan Engelhardt 5,657,555 10,593,238 406,934 13,704,575","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"failed"}],"fact_type":"shareholder_vote"},{"claim_id":"d16f12411b57ca126452b0cf1075bb3e4bedbde2","claim":"Lifeward Ltd. shareholders approved To approve the Company’s restated Compensation Policy for directors and officers.","evidence_excerpt":"Proposal No. 4: To approve the Company’s restated Compensation Policy for directors and officers. For Against Abstain Broker Non-Votes 4,819,032 1,760,888 10,077,808 13,704,575","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"e2d02c6c45a0df3f200920c6938625b7b922976c","claim":"Lifeward Ltd. shareholders approved Subject to the approval of Proposal 5, and if the Board determines to effect a reverse share split pursuant thereto, to approve amendments to the Company’s Articles of Association authorizing an increase in the Company’s authorized share capital.","evidence_excerpt":"Proposal No. 6: Subject to the approval of Proposal 5, and if the Board determines to effect a reverse share split pursuant thereto, to approve amendments to the Company’s Articles of Association authorizing an increase in the Company’s authorized share capital . For Against Abstain Broker Non-Votes 24,525,820 4,914,424 922,055 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"e4be8bb321b6b9a8d91a64930e3beda26b55a9ab","claim":"Lifeward Ltd. shareholders approved To authorize the Board to determine whether to effect a reverse share split of the Company’s outstanding ordinary shares, par value NIS 0.25 each, and if so, to set a ratio within a range of 1-for-2 to 1-for-12, to be effective on a date to be determined by the Board, and to approve conforming amend.","evidence_excerpt":"Proposal No. 5: To authorize the Board to determine whether to effect a reverse share split of the Company’s outstanding ordinary shares, par value NIS 0.25 each, and if so, to set a ratio within a range of 1-for-2 to 1-for-12, to be effective on a date to be determined by the Board, and to approve conforming amendments to the Company’s Articles of Association to reflect any such reverse share split . For Against Abstain Broker Non-Votes 26,454,420 3,794,752 113,127 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"eb088149814d39d8bbea622b86a8c716301779b2","claim":"Lifeward Ltd. shareholders approved To approve the extension of the term of the Consulting Agreement with Richner Consultants, LLC, a Delaware company owned by Randel E. Richner, a member of the Board.","evidence_excerpt":"Proposal No. 3: To approve the extension of the term of the Consulting Agreement with Richner Consultants, LLC, a Delaware company owned by Randel E. Richner, a member of the Board . For Against Abstain Broker Non-Votes 14,966,985 1,004,515 686,227 13,704,575","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891323003188/0001178913-23-003188-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}